|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
Change in substantial holding
IMM released this announcement to the ASX on 8 April 2022, 8:20. The announcement is not marked as price sensitive, and is 6 page(s) in length and 1.21MB in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.399% short sold according to ASIC data. It was ranked the 140th most shorted stock on the ASX. It remains ranked 219th as of the latest reported data (09 November 2026).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Change in substantial holding | 8 April 2022, 8:20 |
| Efti with Keytruda shows encouraging activity in lung cancer | 30 March 2022, 8:24 |
| Immutep announces publication of ELCC 2022 abstract | 24 March 2022, 8:19 |
| Immutep to present Phase IIb breast cancer data at ESMO 2022 | 18 March 2022, 16:18 |
If you were already registered, log in here.